The present study was designed to evaluate neurotensin as a hormonal regulator of gastric acid secretion in man. After a fat-rich meal, the strongest known stimulus of neurotensin release, plasma neurotensin-like immunoreactivity (NTLI) was elevated from 7.6±1.9 to 15.5±2.5 pM. Plasma NTLI was measured with antiserum L170, which requires the biologically active carboxyl-terminal hexapeptide of the neurotensin molecule for recognition and does not crossreact significantly with any known natural catabolite in human plasma.
Introduction
Neurotensin, pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-ProTyr-Ile-Leu-OH, a candidate regulator of gastric functions, was originally isolated from bovine hypothalamus (1) . Related peptides have been immunologically detected in species throughout evolutionary stages from the primitive organism Escherichia Coli (2) to the Homo sapiens (3, 4) . During evolution, the carboxyl-terminal neurotensin-like immunoreactivity (NTLI)' has been conserved (5, 6) . The carboxyl-terminal hexapeptide is required for biological activity (7) , whereas no action has been positively identified for amino-terminal fragments. Tissue concentrations ofNTLI determined by different region specific antisera vary considerably, indicating neuroten-sin molecular heterogeneity. In mammals, intact neurotensin is found in endocrine-like N cells predominantly in the distal small intestine, whereas it is sparse in the stomach (8) . In contrast, high levels ofa smaller molecule with carboxyl-terminal NTLI have been found in rat gastric tissues (9) . Neurotensin has been suggested to be a hormonal regulator of postprandial gastrointestinal functions since NTLI is elevated in peripheral blood after a meal, and intravenous administration of this peptide affects various gastrointestinal functions (10) and causes inhibition of gastric acid secretion (11). However, critical analysis reveals that a hormonal role for neurotensin cannot be concluded from studies performed so far. In previous studies on neurotensin-induced acid secretory inhibition, neurotensin was measured by radioimmunoassay (RIA) in nonextracted plasma (10, 12, 13) and/or with amino-terminally directed antiserum (10). Such measurements may result in artificially high values and do not necessarily reflect biologically active circulating levels. Chromatographic examinations indicate that most of the elevation of plasma NTLI after a meal corresponds to the amino-terminal catabolites NT 1-8 and NT 1-1 1, whereas the bioactive parent peptide NT 1-13 only accounts for a minor fraction ( 14-16). An antiserum specific for the biologically active portion of neurotensin was employed in the present study to determine whether or not the postprandial rise in neurotensin could account for hormonal inhibition of acid secretion, and it is concluded that it does not.
Methods
Physiological studies. Studies were performed on eight healthy male volunteers: mean age, 32±4 (18-41) yr, mean weight, 78±4 (63-92) kg. The study was approved by the Veterans Administration Wadsworth Committee on Human Studies, and informed consent was obtained from each subject. Synthetic neurotensin was administered under IND 23 018 of the Food and Drug Administration.
After an overnight fast, a double-lumen tube was introduced into the stomach. The position ofthe tube was checked by a water recovery test. After complete emptying ofthe stomach by aspiration, 500 ml ofa 6% glucose solution was instilled intragastrically and acid secretion was quantified by automated intragastric titration at pH 5.5 (17). This procedure of liquid meal administration was repeated five times using 8% peptone (Bacto Peptone; Difco Laboratories Inc., Detroit, MI).
All subjects were studied on three separate days in random order. On 1 d, synthetic human neurotensin (Peninsula Laboratories, Inc., Belmont, CA), dissolved in 0.15 M NaCl containing 0.25% human serum albumin, was infused into the left antecubital vein during the last three peptone meals at sequentially increasing doses each of 30 min duration: 100, 400, and 1,600 pmol * kg-' h-'. On a 2nd d, only vehicle was infused. On a 3rd d, the subjects were given a fat-rich meal consisting of 88 g fat, two slices bread, 4 oz cream cheese, and 1 qt milk.
Pilot experiments revealed that the plasma NTLI level obtained after a fat-rich meal could be reproduced by intravenous infusion of neurotensin at 25 pmol * kg-' h-'. To evaluate the effect ofa physiological plasma NTLI level on gastric acid secretion, six ofthe eight volunteers were reexamined using similar methods as described above. Basal acid output was measured by suction aspiration for 30 min, and peptone meal-stimulated acid output was measured by intragastric titration during 2 h (four 30-min peptone meals). In random order on two different days, the subjects received neurotensin or vehicle intravenously during the 2-h peptone meal stimulation. Plasma samples for NTLI measurements were obtained at 30 min intervals.
RIA. Blood samples were collected into chilled tubes, containing 500 kIU aprotinin (Trasylol; Bayer, FRG) and 0.13 mg EDTA per ml whole blood, from a needle in the right antecubital vein and centrifuged at 4VC for 10 min. The plasma was stored at -20'C until measured by RIA for gastrin with antiserum 1611 (18) and for neurotensin with antiserum L170 (19), as previously described. To concentrate neurotensin and to eliminate nonspecific assay interference, 3 ml of plasma was extracted on Sep Pak C18 cartridges (Waters Associates, Milford, MA), as previously described (19) . The recoveries of synthetic neurotensin added to hormone-free plasma to obtain plasma levels of 0, 10, 15, 25, 50, 100, and 500 pM were 0, 105±15, 86±11, 92±6, 84±6, 88±8, and 85±6%, respectively (n = 8). The relative immunoreactivity, as determined by the amount of peptide needed to inhibit by 50% the binding of iodinated neurotensin in the RIA, is demonstrated in Table I . Neurotensin antiserum L170 requires the biologically active carboxyl-terminal hexapeptide of the neurotensin molecule for recognition and does not cross-react significantly with any known natural catabolite in human plasma. On gel permeation chromatography (see below) of postprandial human plasma, only one homogenous peak of carboxyl-terminal NTLI was detected, confirming observations by others (14, 15) . This material may be identified as neurotensin since equal amounts ofamino-and carboxyl-terminal NTLI were measured. Gelpermeation chromatography ofpostprandialplasma NTLI. 100 ml plasma from one subject was obtained at 30 min after the fat meal. The plasma NTLI was extracted on Sep Pak C18 cartridges and concentrated by rotary evaporation. An analytical amount of 2 ml was characterized on an analytical Sephadex G-50 column (1.5 X 100 cm) equilibrated and eluted with 0.05 M CH3CO2NH4 at pH 5.5. The eluted fractions were assayed for NTLI by RIA with antisera L170 and 7852 (20) .
Data analysis. The data are presented as mean and standard errors. The range is given in parentheses after data. Repeated measures analysis of variance was used to evaluate significance ofdifferences between the experimental groups, and P < 0.05 was considered as significant.
Results
Acid secretion (Fig. 1) . The gastric acid secretory responses to the glucose meal were 4.6±1.0 (0-8.5) and 5.1±1.7 (0-11.2) mmol * 30 min-' in the control and test experiment, respectively. The peptone meal significantly stimulated acid output to 9.1±2.5 (2.8-22.7) and 9.4±2.1 (1.8-17.7) mmol* 30 min-' Endogenous NTLI release (Fig. 3) . Basal plasma NTLI was 7.6±1.9 (2-17) pM. After ingestion of a fat-rich meal, plasma NTLI was significantly elevated to a mean peak maximum of 15.5±2.5 (4-24) pM at 40 min (Fig. 3) . Plasma NTLI was back to basal at 100 min.
Gel permeation chromatography ofpostprandial plasma NTLI (Fig. 4) . The Sephadex G-50 chromatogram (Fig. 4) infusion required a supra-physiological plasma NTLI level of 130 pM (21) . Gastrin release was unaffected by exogenous administration of neurotensin, indicating that neurotensin-induced inhibition of gastric acid secretion in man is independent of the hormone gastrin, as previously reported by Olsen and coworkers (13). A direct effect of neurotensin on the parietal cell is unlikely since attempts to demonstrate a neurotensin receptor were negative (22), neurotensin does not inhibit acid secretion stimulated by histamine (11), and neurotensin-induced inhibition is abolished by vagotomy (23) .
Neurotensin-like immunoreactivity in plasma. The neurotensin RIA methodology used in the present study has been validated (19) and differs from methods used in previous studies on acid secretion in man with regard to specificity of antiserum and/or extraction procedure. In one previous study (10), an amino-terminally directed antiserum was used. Such antiserum may cross-react with neurotensin catabolites, the main components of plasma NTLI (14-16) that are cleared at slower rates than is neurotensin itself (24) and for which no biological activity on gastric functions has been positively identified (23) . In other previous studies that employed carboxyl-terminally directed antisera (12, 13), measurements were performed on plasma without extraction, resulting in artificially high values due to nonspecific interference by plasma components (25) .
The chromatographic characterization of Sep Pak-extracted postprandial plasma NTLI in the present study, Fig. 4 (14, 15) . Characterization by high performance liquid chromatography of human plasma, obtained before and after a meal, failed to demonstrate an increase in carboxyl-terminal NTLI, whereas amino-terminal NTLI was significantly elevated (16). On the other hand, the present and other studies (14, 15) in which plasma was taken at earlier time points have demonstrated carboxyl-terminal immunoreactivity in human plasma that appears to be intact neurotensin. Very high levels of carboxyl-terminal NTLI in acid-acetone-extracted human plasma have been reported (26), but not found by other investigators, a fact which may be attributed to the extreme carboxyl-terminal specificity of the antiserum employed, PGL4, and/or generation of NTLI during the extraction. The chromatographic profile of postprandial plasma in the present study is comparable with that of plasma obtained during infusion ofsynthetic neurotensin (27) .
In summary, neurotensin inhibited parietal cell function by a mechanism that did not involve inhibition of gastrin release, but is not likely to function as a physiologically significant hormonal regulator of gastric acid secretion in man since no effect was observed at physiological plasma levels.
